Pulmonary hypertension
- PMID: 26929415
- PMCID: PMC9487661
- DOI: 10.1183/16000617.0096-2015
Pulmonary hypertension
Abstract
In 2015, more than 800 papers were published in the field of pulmonary hypertension. A Clinical Year in Review article cannot possibly incorporate all this work and needs to be selective. The recently published European guidelines for the diagnosis and treatment of pulmonary hypertension contain an inclusive summary of all published clinical studies conducted until very recently. Here, we provide an overview of papers published after the finalisation of the guideline. In addition, we summarise recent advances in pulmonary vasculature science. The selection we made from the enormous amount of published work undoubtedly reflects our personal views and may not include all papers with a significant impact in the near or more distant future. The focus of this paper is on the diagnosis of pulmonary arterial hypertension, understanding the success of combination therapy on the right ventricle and scientific breakthroughs.
Copyright ©ERS 2016.
Conflict of interest statement
Conflict of interest: Disclosures can be found alongside the online version of this article at
Similar articles
-
Clinical advances in pulmonary arterial hypertension: the year in review.Curr Opin Pulm Med. 2013 Sep;19(5):430-6. doi: 10.1097/MCP.0b013e3283644c8d. Curr Opin Pulm Med. 2013. PMID: 23907455 Review.
-
An overview of pulmonary arterial hypertension: risks, pathogenesis, clinical manifestations, and management.J Cardiovasc Nurs. 2005 Mar-Apr;20(2):108-16; quiz 117-8. doi: 10.1097/00005082-200503000-00005. J Cardiovasc Nurs. 2005. PMID: 15855858 Review.
-
Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease.Eur Respir Rev. 2011 Dec;20(122):236-42. doi: 10.1183/09059180.00006711. Eur Respir Rev. 2011. PMID: 22130816 Free PMC article. Review.
-
Epidemiology and Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: Risk Factors and Mechanisms.Methodist Debakey Cardiovasc J. 2016 Oct-Dec;12(4):195-198. doi: 10.14797/mdcj-12-4-195. Methodist Debakey Cardiovasc J. 2016. PMID: 28289493 Free PMC article. Review.
-
Pulmonary arterial hypertension in children.Eur Respir J. 2003 Jan;21(1):155-76. doi: 10.1183/09031936.03.00088302. Eur Respir J. 2003. PMID: 12570125 Review.
Cited by
-
Pulmonary Hypertension and Right Ventricle: A Pathophysiological Insight.Clin Med Insights Cardiol. 2024 Sep 9;18:11795468241274744. doi: 10.1177/11795468241274744. eCollection 2024. Clin Med Insights Cardiol. 2024. PMID: 39257563 Free PMC article. Review.
-
Mendelian randomization study on causal association of TEF and circadian rhythm with pulmonary arterial hypertension.Respir Res. 2024 Aug 7;25(1):301. doi: 10.1186/s12931-024-02934-8. Respir Res. 2024. PMID: 39113039 Free PMC article.
-
A Lifelike guided journey through the pathophysiology of pulmonary hypertension-from measured metabolites to the mechanism of action of drugs.Front Cardiovasc Med. 2024 May 23;11:1341145. doi: 10.3389/fcvm.2024.1341145. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38845688 Free PMC article.
-
The pharmaco-epigenetics of hypertension: a focus on microRNA.Mol Cell Biochem. 2024 Dec;479(12):3255-3271. doi: 10.1007/s11010-024-04947-9. Epub 2024 Feb 29. Mol Cell Biochem. 2024. PMID: 38424404 Free PMC article. Review.
-
Rapid Onset Idiopathic Pulmonary Hypertension: A Case Report with a Review of Echocardiographic Parameters.J Cardiovasc Echogr. 2023 Jan-Mar;33(1):43-48. doi: 10.4103/jcecho.jcecho_13_23. Epub 2023 May 29. J Cardiovasc Echogr. 2023. PMID: 37426715 Free PMC article.
References
-
- Galiè N, Humbert M, Vachiery J-L, et al. . 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2015; 46: 903–975. - PubMed
-
- Simonneau G, Gatzoulis MA, Adatia I, et al. . Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62: Suppl. 25, D34–D41. - PubMed
-
- Alves JL, Gavilanes F, Jardim C, et al. . Pulmonary arterial hypertension in the southern hemisphere: results from a registry of incident Brazilian cases. Chest 2015; 147: 495–501. - PubMed
-
- Eyries M, Montani D, Girerd B, et al. . EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension. Nat Genet 2014; 46: 65–69. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical